|
Understanding the Link Between Type 2 Diabetes and Chronic Kidney Disease
|
Written by: J. Smith |
Hits: 226
|
|
GLP-1 Receptor Agonists: A New Hope for Obstructive Sleep Apnea and Chronic Kidney Disease
|
Written by: J. Smith |
Hits: 211
|
|
Novo Nordisk's Stance on Semaglutide for Cosmetic Use
|
Written by: J. Smith |
Hits: 279
|
|
Eli Lilly's Stance on Tirzepatide for Cosmetic Use
|
Written by: J. Smith |
Hits: 390
|
|
FDA's Ongoing Evaluation of GLP-1 RAs: No Clear Link Found Between Medication and Suicidal Thoughts or Actions
|
Written by: J. Smith |
Hits: 217
|
|
Join the 5K@EASD Virtual Run/Walk for Diabetes Awareness 2024
|
Written by: J. Smith |
Hits: 281
|
|
Dexcom's Stelo: A New Era for Type 2 Diabetes Management
|
Written by: J. Smith |
Hits: 357
|
|
Novo Nordisk Announces Positive Results in Phase 3a Trial of IcoSema, a Combination of Semaglutide and Insulin Icodec for Type 2 Diabetes
|
Written by: J. Smith |
Hits: 280
|
|
Data Analytics for Type 2 Diabetes
|
Written by: J. Smith |
Hits: 266
|
|
Studies of Cinnamon for Blood Sugar Control: Mixed Results with No Clear Answer
|
Written by: J. Smith |
Hits: 266
|
